Ryan Pruchnic is listed as a director on 5 SEC Form D filings by 1 issuer between Sep 2023 and Apr 2025: LIPELLA PHARMACEUTICALS INC. (Pittsburgh, PA — pharmaceuticals — 2023–2025; $3.12M reported sold to 43 investors).
What this means One deal on file with the SEC. A Form D is the notice a company files after it starts selling a private investment — it is a notice, not an approval.
Listed alongside Byong Kim (5 shared filings), Daniel Cohen (5 shared filings), Douglas Johnston (5 shared filings), JONATHAN KAUFMAN (5 shared filings), Lori Birder (5 shared filings) and 2 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Ryan. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — none found.
What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.
We compared 5 public filings for Ryan Pruchnic and found 3 differences, 1 worth asking the sponsor about: Form D filed 64 days after the first sale; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.